These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31687050)

  • 21. The relationship between post-procedural platelet count and left ventricular aneurysm in patients with acute anterior ST-segment elevation myocardial infarction following primary percutaneous coronary intervention.
    Wang Z; Ren L; Liu N; Peng J
    Kardiol Pol; 2018; 76(5):899-907. PubMed ID: 29313561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multibiomarker analysis in patients with acute myocardial infarction.
    Schernthaner C; Lichtenauer M; Wernly B; Paar V; Pistulli R; Rohm I; Jung C; Figulla HR; Yilmaz A; Cadamuro J; Haschke-Becher E; Pernow J; Schulze PC; Hoppe UC; Kretzschmar D
    Eur J Clin Invest; 2017 Sep; 47(9):638-648. PubMed ID: 28683166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Independent and incremental prognostic value of novel cardiac biomarkers in chronic hemodialysis patients.
    Obokata M; Sunaga H; Ishida H; Ito K; Ogawa T; Ando Y; Kurabayashi M; Negishi K
    Am Heart J; 2016 Sep; 179():29-41. PubMed ID: 27595677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Value and level of galectin-3 in acute myocardial infarction patients undergoing primary percutaneous coronary intervention.
    Tsai TH; Sung PH; Chang LT; Sun CK; Yeh KH; Chung SY; Chua S; Chen YL; Wu CJ; Chang HW; Ko SF; Yip HK
    J Atheroscler Thromb; 2012; 19(12):1073-82. PubMed ID: 23037954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of soluble ST2 biomarker in heart failure patients with reduced ejection fraction - A multicenter study.
    Bahuleyan CG; Alummoottil GK; Abdullakutty J; Lordson AJ; Babu S; Krishnakumar VV; Pillai AM; Abraham G; Dilip MN
    Indian Heart J; 2018 Jul; 70 Suppl 1(Suppl 1):S79-S84. PubMed ID: 30122243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Galectin-3 and soluble RAGE as new biomarkers of post-infarction cardiac remodeling.
    Redondo A; Paradela-Dobarro B; Moscoso I; Moure-Álvarez M; Cebro-Márquez M; González-Juanatey JR; García-Seara J; Álvarez E
    J Mol Med (Berl); 2021 Jul; 99(7):943-953. PubMed ID: 33641068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Left Atrial Function Determined by Echocardiography Predicts Incident Heart Failure in Patients With STEMI treated by Primary Percutaneous Coronary Intervention.
    Modin D; Pedersen S; Fritz-Hansen T; Gislason G; Biering-Sørensen T
    J Card Fail; 2020 Jan; 26(1):35-42. PubMed ID: 31454686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential and Predictive Value of Galectin-3 and Soluble Suppression of Tumorigenicity-2 (sST2) in Heart Failure with Preserved Ejection Fraction.
    Cui Y; Qi X; Huang A; Li J; Hou W; Liu K
    Med Sci Monit; 2018 Jul; 24():5139-5146. PubMed ID: 30039808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Value of Soluble ST2 After Myocardial Infarction: A Community Perspective.
    Jenkins WS; Roger VL; Jaffe AS; Weston SA; AbouEzzeddine OF; Jiang R; Manemann SM; Enriquez-Sarano M
    Am J Med; 2017 Sep; 130(9):1112.e9-1112.e15. PubMed ID: 28344136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of plasma-soluble ST2 and galectin-3 with cardiovascular events and mortality following cardiac surgery.
    Patel DM; Thiessen-Philbrook H; Brown JR; McArthur E; Moledina DG; Mansour SG; Shlipak MG; Koyner JL; Kavsak P; Whitlock RP; Everett AD; Malenka DJ; Garg AX; Coca SG; Parikh CR
    Am Heart J; 2020 Feb; 220():253-263. PubMed ID: 31911262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of prognostic significance for major adverse cardiac events of soluble suppression of tumorigenicity 2 levels in patients with ST-segment elevation myocardial infarction.
    Kim M; Lee DI; Lee JH; Kim SM; Lee SY; Hwang KK; Kim DW; Cho MC; Bae JW
    Cardiol J; 2021; 28(2):244-254. PubMed ID: 32104902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive value of soluble suppression of tumourigenicity 2 on myocardial reperfusion.
    Bai S; Liu H; Wu H; Wang X; Li R; Li X; Li X; Zhang L; Chen T; Du R
    Intern Med J; 2020 Aug; 50(8):985-992. PubMed ID: 31566840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Galectin-3 Levels and Outcomes After Myocardial Infarction: A Population-Based Study.
    Asleh R; Enriquez-Sarano M; Jaffe AS; Manemann SM; Weston SA; Jiang R; Roger VL
    J Am Coll Cardiol; 2019 May; 73(18):2286-2295. PubMed ID: 31072572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presence of post-systolic shortening is an independent predictor of heart failure in patients following ST-segment elevation myocardial infarction.
    Brainin P; Haahr-Pedersen S; Sengeløv M; Olsen FJ; Fritz-Hansen T; Jensen JS; Biering-Sørensen T
    Int J Cardiovasc Imaging; 2018 May; 34(5):751-760. PubMed ID: 29230597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma Biomarkers Reflecting Profibrotic Processes in Heart Failure With a Preserved Ejection Fraction: Data From the Prospective Comparison of ARNI With ARB on Management of Heart Failure With Preserved Ejection Fraction Study.
    Zile MR; Jhund PS; Baicu CF; Claggett BL; Pieske B; Voors AA; Prescott MF; Shi V; Lefkowitz M; McMurray JJ; Solomon SD;
    Circ Heart Fail; 2016 Jan; 9(1):. PubMed ID: 26754625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ST2 elevation in heart failure, predictive of a high early mortality.
    Dalal JJ; Digrajkar A; Das B; Bansal M; Toomu A; Maisel AS
    Indian Heart J; 2018; 70(6):822-827. PubMed ID: 30580851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Galectin-3 and ST2 as predictors of therapeutic success in high-risk patients undergoing percutaneous mitral valve repair (MitraClip).
    Dörr O; Walther C; Liebetrau C; Keller T; Sommer T; Boeder N; Bayer M; Bauer P; Möllmann H; Gaede L; Troidl C; Voss S; Bauer T; Hamm CW; Nef H
    Clin Cardiol; 2018 Sep; 41(9):1164-1169. PubMed ID: 29896861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relation of endocan and galectin-3 with ST-segment resolution in patients with ST-segment elevation myocardial infarction.
    Turan Y; Demir V
    Adv Clin Exp Med; 2020 Apr; 29(4):453-458. PubMed ID: 32343887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Galectin-3 and outcomes after anterior-wall myocardial infarction treated by primary percutaneous coronary intervention.
    Di Tano G; Caretta G; De Maria R; Bettari L; Parolini M; Testa S; Pirelli S
    Biomark Med; 2018 Jan; 12(1):21-26. PubMed ID: 29243525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating Galectin-3 Levels Are Increased in Patients with Ischemic Heart Disease, but Are Not Influenced by Acute Myocardial Infarction.
    Singsaas EG; Manhenke CA; Dickstein K; Orn S
    Cardiology; 2016; 134(4):398-405. PubMed ID: 27120522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.